Apollomics
APLM | NASDAQ
$17.84
+$0.16 (+0.90%)
At close: Nov 16, 2026, 4:00 PM ET
$17.51
-$0.33 (-1.85%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+0.90%
(1D)No price chart data available for 1D timeframe.
Rating
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #823/1021 (Top 81%)
Key Statistics
Market Data
Market Cap $52M
1D Range
16.60 18.52
52W Range
12.85 28.01
Valuation (TTM)
PE -68.62
PB -4.81
EV/EBITDA -9.44
Valuation (NTM)
Forward PE N/A
Forward PEG -2.09
Price Target $0.00
Cash Flow
FCF Yield -34.6%
SBC Adj. FCF Yield -39.0%
SBC Impact -12.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -30.8% |
35.8%
Dil EPS 3Y | 5Y 4.0% |
5.4%
FCF 3Y | 5Y 59.8% |
27.0%
Returns
ROA -326.1%
ROE 103.1%
ROIC 105.4%
Financial Health
Net Debt
$492K
Current Ratio 0.15
Interest Coverage -47.53
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, C...
Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Nov 26, 2021
Website www.apollomicsinc.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove APLM